1. Home
  2. MAIA vs BYFC Comparison

MAIA vs BYFC Comparison

Compare MAIA & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • BYFC
  • Stock Information
  • Founded
  • MAIA 2018
  • BYFC 1946
  • Country
  • MAIA United States
  • BYFC United States
  • Employees
  • MAIA N/A
  • BYFC N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • BYFC Savings Institutions
  • Sector
  • MAIA Health Care
  • BYFC Finance
  • Exchange
  • MAIA Nasdaq
  • BYFC Nasdaq
  • Market Cap
  • MAIA 65.9M
  • BYFC 61.4M
  • IPO Year
  • MAIA 2022
  • BYFC 1996
  • Fundamental
  • Price
  • MAIA $2.13
  • BYFC $7.20
  • Analyst Decision
  • MAIA
  • BYFC
  • Analyst Count
  • MAIA 0
  • BYFC 0
  • Target Price
  • MAIA N/A
  • BYFC N/A
  • AVG Volume (30 Days)
  • MAIA 163.9K
  • BYFC 7.9K
  • Earning Date
  • MAIA 11-12-2024
  • BYFC 10-29-2024
  • Dividend Yield
  • MAIA N/A
  • BYFC N/A
  • EPS Growth
  • MAIA N/A
  • BYFC N/A
  • EPS
  • MAIA N/A
  • BYFC 0.26
  • Revenue
  • MAIA N/A
  • BYFC $35,113,000.00
  • Revenue This Year
  • MAIA N/A
  • BYFC N/A
  • Revenue Next Year
  • MAIA N/A
  • BYFC N/A
  • P/E Ratio
  • MAIA N/A
  • BYFC $29.05
  • Revenue Growth
  • MAIA N/A
  • BYFC 12.14
  • 52 Week Low
  • MAIA $0.82
  • BYFC $4.41
  • 52 Week High
  • MAIA $5.99
  • BYFC $7.99
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 33.62
  • BYFC 60.94
  • Support Level
  • MAIA $2.42
  • BYFC $6.52
  • Resistance Level
  • MAIA $3.48
  • BYFC $7.59
  • Average True Range (ATR)
  • MAIA 0.29
  • BYFC 0.36
  • MACD
  • MAIA -0.06
  • BYFC 0.06
  • Stochastic Oscillator
  • MAIA 1.46
  • BYFC 87.18

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

Share on Social Networks: